Abstract
The aim of this chapter is to discuss the current literature surrounding the science that underlies heart failure. This encompasses the natural history of the syndrome, namely, an initial myocardial insult, apparent recovery, decompensation and finally failure of the organ. We will then expand upon some of the post-infarction changes to ventricular performance in both the compensatory and failure stages, including their manifestations on the Frank–Starling curve. Finally, the topic of cardiac regeneration will briefly be analysed. Understanding the science behind regeneration will provide a foundation to appreciate the basis of novel therapies, discussed later.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Davis RC (2000) ABC of heart failure: history and epidemiology. BMJ 320:297
Cowie MR (2017) The heart failure epidemic: a UK perspective. Echo Res Pract 4:R15
Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend N (2015) The epidemiology of cardiovascular disease in the UK 2014. Heart 101:1182
Azevedo PS, Polegato BF, Minicucci MF, Paiva SAR, Zornoff LAM (2016) Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol 106(1):62–69
Pazos-López P, Peteiro-Vázquez J, Carcía-Campos A, García-Bueno L, de Torres JPA, Castro-Beiras A (2011) The causes, consequences, and treatment of left or right heart failure. Vasc Health Risk Manag 7:237–254
Frangogiannis NG (2014) The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11:255
Algranati D, Kassab GS, Lanir Y (2011) Why is the subendocardium more vulnerable to ischemia? A new paradigm. AJP Hear Circ Physiol 300:H1090
Burchfield JS, Xie M, Hill JA (2013) Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation 128:388
Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE (1995) Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92:2540
Gerdes AM, Kellerman SE, Moore JA, Muffly KE, Clark LC, Reaves PY et al (1992) Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation 86:426
Savinova OV, Gerdes AM (2012) Myocyte changes in heart failure. Heart Fail Clin 8:1
Botchway AN, Turner MA, Sheridan DJ, Flores NA, Fry CH (2003) Electrophysiological effects accompanying regression of left ventricular hypertrophy. Cardiovasc Res 60:510
Terracciano CMN, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH (2004) Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 109(19):2263–2265
Cohn JN, Tognoni G (2001) (Val-HeFT Trial) a randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345(23):1667–1675
Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T et al (1993) Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87(6 Suppl):VI5–V16
Bernstein D, Fajardo G, Zhao M (2011) The role of β-adrenergic receptors in heart failure: differential regulation of cardiotoxicity and cardioprotection. Prog Pediatr Cardiol 31:35
Madamanchi A (2007) β-adrenergic receptor signaling in cardiac function and heart failure. McGill J Med 10(2):99–104
He BJ, Joiner MLA, Singh MV, Luczak ED, Swaminathan PD, Koval OM et al (2011) Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat Med 17:1610
Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT (1991) Cardiac myocyte necrosis induced by angiotensin II. Circ Res 69:1185
Ogawa M, Morita N, Tang L, Karagueuzian HS, Weiss JN, Lin SF et al (2009) Mechanisms of recurrent ventricular fibrillation in a rabbit model of pacing-induced heart failure. Hear Rhythm 6:784
Borlaug BA, Paulus WJ (2011) Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 32(6):670–679
Nishimura RA, Jaber W (2007) Understanding “diastolic heart failure”. J Am Coll Cardiol 49:695
Toischer K, Rokita AG, Unsöld B, Zhu W, Kararigas G, Sossalla S et al (2010) Differential cardiac remodeling in preload versus afterload. Circulation 122(10):993–1003
Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R et al (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42(7):1226–1233
Van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L et al (2014) Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 16(1):103–111
Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B et al (2016) Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ 354:i4857
Crofford LJ (2013) Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 15(Suppl 3):S2
Lymperopoulos A, Rengo G, Koch WJ (2013) Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 113(6):739–753
Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heide F, Walsh S et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324(5923):98–102
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chick, G., Pitoulis, F.G., Couch, L. (2019). The Scientific Basis of Heart Failure. In: Terracciano, C., Guymer, S. (eds) Heart of the Matter. Learning Materials in Biosciences. Springer, Cham. https://doi.org/10.1007/978-3-030-24219-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-24219-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24218-3
Online ISBN: 978-3-030-24219-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)